Clinical Trials Logo

Clinical Trial Summary

Chronic suppurative otitis media (CSOM) is characterized by intermittent or continuous otorrhea lasting for longer than 6 weeks. Most cases can be treated conservatively using antibiotic drops and oral antibiotics. However, some cases will not respond to conservative treatment and demonstrate persistant discharge. In these cases, especially if a CT-scan shows opacification of the mastoid air cells, a mastoidectomy can be considered as treatment modality. In recent years, obliteration of the mastoid cavity following mastoidectomy is gaining popularity. However, the effectiveness of obliterating the mastoid in comparison to mastoidectomy alone is uncertain for CSOM. In this retrospective cohort study, our aim is to compare mastoidectomy to mastoidectomy + mastoid obliteration in a cohort of patients suffering from CSOM with mastoid involvement. The hypothesis is that obliterating the mastoid cavity will result in a higher frequency of dry ears and in a lower frequency of revision surgeries.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06160505
Study type Observational
Source Diakonessenhuis, Utrecht
Contact Leij-Halfwerk, Msc, Ir
Phone 0882506172
Email Wetenschapsbureau@diakhuis.nl
Status Recruiting
Phase
Start date October 1, 2023
Completion date June 1, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT02779907 - Prevalence and Associations of Paediatric Chronic Suppurative Otitis Media and Hearing Impairment in Rural Malawi N/A
Completed NCT05133258 - Antibiotic Concentration After Delivery to Middle Ear for Chronic Suppurative Otitis Media
Recruiting NCT03675841 - Pazufloxacin Mesilate Ear Drops in Patients With Chronic Suppurative Otitis Media Phase 1
Completed NCT05657717 - Safety Profile of Applied 100% Manuka Honey in Tympanoplasty Phase 2/Phase 3
Completed NCT05967845 - Platelet Rich Fibrin Augmented Tympanoplasty Versus Cartilage Tympanoplasty N/A